Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
Public ClinicalTrials.gov record NCT00130390. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease in Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy and safety of nitazoxanide compared to a placebo in reducing the signs and symptoms of mild to moderate active Crohn's disease in adults.
Study identification
- NCT ID
- NCT00130390
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 98 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2005 (Type not available)
- Primary completion
- Dec 2007 (Actual)
- Completion
- Jul 2008 (Actual)
- Last update posted
- May 31, 2012
2005 – 2008
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Romark Laboratories, L.C. | Tampa | Florida | 33607 | — |
| Florida medical Clinic, P.A. | Zephyrhills | Florida | 33542 | — |
| Atlanta Gastroenterology | Marietta | Georgia | 30067 | — |
| Atlanta Gastroenterology | Woodstock | Georgia | 30189 | — |
| Gasteroenterology Associates | Baton Rouge | Louisiana | 70809 | — |
| Minnesota Gastroenterology, P.A., Clinical Research Division | Plymouth | Minnesota | 55446 | — |
| Long Island Clinical Research Associates, LLP | Great Neck | New York | 11021 | — |
| Greater Cincinnati Gastroenterology Associates | Cincinnati | Ohio | 45219 | — |
| Digestive Research & Infusion Institute | Mayfield Heights | Ohio | 44124 | — |
| Oklahoma Foundation for Digestive Research | Oklahoma City | Oklahoma | 73104 | — |
| Memphis Gastroenterology Group | Germantown | Tennessee | 38138 | — |
| Gastrointestinal Associates, LLC | Kingsport | Tennessee | 37660 | — |
| Nashville Medical Research | Nashville | Tennessee | 37205 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00130390, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2012 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00130390 live on ClinicalTrials.gov.